Latest Insider Transactions at Solid Biosciences Inc. (SLDB)
This section provides a real-time view of insider transactions for Solid Biosciences Inc. (SLDB). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Solid Biosciences Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Solid Biosciences Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 03
2022
|
Ian F Smith |
BUY
Exercise of conversion of derivative security
|
Direct |
24,312
+6.62%
|
-
|
|
Jul 03
2022
|
Ian F Smith |
BUY
Exercise of conversion of derivative security
|
Direct |
24,313
+7.08%
|
-
|
|
Apr 03
2022
|
Ian F Smith |
BUY
Exercise of conversion of derivative security
|
Direct |
24,313
+7.62%
|
-
|
|
Mar 14
2022
|
Joel Solomon Zev Schneider Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
30,504
-5.89%
|
$30,504
$1.1 P/Share
|
|
Mar 14
2022
|
Carl Ashley Morris Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
22,665
-4.16%
|
$22,665
$1.1 P/Share
|
|
Feb 10
2022
|
Ilan Ganot |
SELL
Open market or private sale
|
Indirect |
463
-15.53%
|
$463
$1.12 P/Share
|
|
Apr 01
2021
|
Ra Capital Management, L.P. Director |
BUY
Other acquisition or disposition
|
Indirect |
1,451,306
+27.71%
|
$7,256,530
$5.53 P/Share
|
|
Mar 23
2021
|
Adam Koppel |
BUY
Grant, award, or other acquisition
|
Indirect |
869,565
+9.88%
|
$4,347,825
$5.75 P/Share
|
|
Mar 23
2021
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
2,608,695
+16.28%
|
$13,043,475
$5.75 P/Share
|
|
Mar 19
2021
|
Ra Capital Management, L.P. Director |
BUY
Open market or private purchase
|
Indirect |
2,206,685
+16.82%
|
$11,033,425
$5.75 P/Share
|
|
Mar 12
2021
|
Joel Solomon Zev Schneider Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
23,398
-4.09%
|
$187,184
$8.84 P/Share
|
|
Mar 12
2021
|
Carl Ashley Morris Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
23,398
-3.99%
|
$187,184
$8.85 P/Share
|
|
Feb 12
2021
|
Ilan Ganot |
SELL
Open market or private sale
|
Indirect |
457
-13.12%
|
$3,199
$7.66 P/Share
|
|
Jan 28
2021
|
Ilan Ganot |
SELL
Open market or private sale
|
Direct |
10,713
-0.89%
|
$64,278
$6.14 P/Share
|
|
Jan 28
2021
|
Carl Ashley Morris Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,459
-1.14%
|
$20,754
$6.14 P/Share
|
|
Jan 28
2021
|
Jennifer Lynn Ziolkowski CFO, Treasurer & Asst. Secy |
SELL
Open market or private sale
|
Direct |
3,473
-1.02%
|
$20,838
$6.14 P/Share
|
|
Jan 28
2021
|
Joel Solomon Zev Schneider Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,443
-1.16%
|
$20,658
$6.14 P/Share
|
|
Jan 27
2021
|
Ilan Ganot |
BUY
Exercise of conversion of derivative security
|
Direct |
35,500
+2.85%
|
-
|
|
Jan 27
2021
|
Carl Ashley Morris Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+3.66%
|
-
|
|
Jan 27
2021
|
Jennifer Lynn Ziolkowski CFO, Treasurer & Asst. Secy |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+3.28%
|
-
|
|
Jan 27
2021
|
Joel Solomon Zev Schneider Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,500
+3.74%
|
-
|
|
Dec 10
2020
|
Perceptive Advisors LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
4,054,054
+27.29%
|
$12,162,162
$3.7 P/Share
|
|
Dec 10
2020
|
Matthew Bennett Arnold Director |
BUY
Grant, award, or other acquisition
|
Direct |
432,432
+9.9%
|
$1,297,296
$3.7 P/Share
|
|
Dec 10
2020
|
Ilan Ganot |
BUY
Grant, award, or other acquisition
|
Direct |
27,027
+2.25%
|
$81,081
$3.7 P/Share
|
|
Dec 10
2020
|
Ian F Smith |
BUY
Grant, award, or other acquisition
|
Direct |
270,270
+50.0%
|
$810,810
$3.7 P/Share
|
|
Dec 10
2020
|
Rajeev M. Shah Director |
BUY
Grant, award, or other acquisition
|
Indirect |
4,938,282
+36.18%
|
$14,814,846
$3.7 P/Share
|
|
Dec 10
2020
|
Adam Koppel |
BUY
Grant, award, or other acquisition
|
Indirect |
3,189,189
+31.12%
|
$9,567,567
$3.7 P/Share
|
|
Jul 25
2019
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
2,822,581
+29.49%
|
$11,290,324
$4.65 P/Share
|
|
Mar 28
2019
|
Boxer Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
60,000
-1.7%
|
$540,000
$9.53 P/Share
|
|
Mar 27
2019
|
Boxer Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
115,000
-3.15%
|
$1,035,000
$9.6 P/Share
|
|
Mar 26
2019
|
Boxer Capital, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
275,000
-7.01%
|
$2,750,000
$10.08 P/Share
|
|
Jan 30
2018
|
Perceptive Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
1,020,000
+10.44%
|
$21,420,000
$21.67 P/Share
|